OptimizeRx OPRX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70%+14.1pp | 67.3%+27.0pp | 65.3%+30.1pp | 64.4%+33.3pp | 55.9%+8.1pp | |
| Net margin | 6.4%+26.4pp | 4.7%+41.4pp | 0%+47.5pp | -9.4%+29.6pp | -20.1%+10.8pp | |
| Returns | ||||||
| Return on equity | 5.6%+18.5pp | 4.2%+20.7pp | 0%+21.0pp | -8.2%+6.9pp | -12.9%+1.8pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×+0.2× | 0.6×+0.3× | 0.7×+0.3× | 0.6×+0.3× | 0.4×+0.1× | |
| Liquidity | ||||||
| Current ratio | 5.4×+2.6× | 3×+0.2× | 3×-0.2× | 2.6×-0.5× | 2.8×-0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×-0.1× | 0.2×-0.1× | 0.2×-0.1× | 0.2×-0.1× | 0.3×0.0× | |
| Per Share | ||||||
| Book value per share | $6.91+9.7% | $6.75+5.6% | $6.28+0.6% | $6.27-5.4% | $6.29-6.7% | |
| Valuation | ||||||
| Market capitalization | $107.34M-54.1% | $228.53M+155% | $380.58M+169% | $238.59M+30.6% | $160.13M-27.4% | |
| Price / sales | 1×-1.2× | 2.1×+0.5× | 3.5×+0.7× | 2.3×-1.7× | 2.1×-1.7× | |
| Price / book | 0.8×-1.1× | 1.8×+1.0× | 3.1×+1.9× | 2×+0.5× | 1.4×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are OptimizeRx's profit margins?
- OptimizeRx (OPRX) runs a 70.0% gross margin and a 13.2% operating margin, with a 6.4% net margin.
- Where do OptimizeRx's ratios come from?
- Every ratio is computed from OptimizeRx's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
